# Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/liraglutide-3-0-mg-saxenda-for-weight-loss-and-remission-of-pre-diabetes-real/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rebekah Wilmington,Arash Ardavani,Amelia Simenacz,Carol Green,Iskandar Idris |
| Citations | 12 |
| DOI | 10.1007/s11695-023-06895-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s11695-023-06895-7.pdf |
| OpenAlex ID | https://openalex.org/W4389068530 |
| PMID | 38012508 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Arash Ardavani](https://scholariq.org/researchers/arash-ardavani/)

## Paper journal

- [Obesity Surgery](https://scholariq.org/journals/obesity-surgery/)

## Paper primary topic

- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

## Paper topics

- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.